Literature DB >> 3889903

Amino acid sequence of a variant pro-form of insulin-like growth factor II.

P P Zumstein, C Lüthi, R E Humbel.   

Abstract

Human serum contains, in addition to the "classical" 7.5-kDa insulin-like growth factors (IGFs) I and II, small amounts of larger IGF-II. A 10-kDa IGF-II was isolated by gel filtration, immunoaffinity chromatography, and reversed-phase HPLC. Upon amino acid sequence determination, a substitution of Cys-Gly-Asp for Ser-33 was found as well as a COOH-terminal extension of 21 residues (E peptide). These sequence differences suggest that 10-kDa IGF-II is a precursor of a variant IGF-II. Since the substitution is not located at a known intron/exon hinge region, the finding of this variant IGF-II is evidence for the presence of more than one gene for IGF-II.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889903      PMCID: PMC397736          DOI: 10.1073/pnas.82.10.3169

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Somatomedin: proposed designation for sulphation factor.

Authors:  W H Daughaday; K Hall; M S Raben; W D Salmon; J L van den Brande; J J van Wyk
Journal:  Nature       Date:  1972-01-14       Impact factor: 49.962

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Production of insulin-like growth factors and their carrier by rat pituitary gland and brain explants in culture.

Authors:  M Binoux; P Hossenlopp; C Lassarre; N Hardouin
Journal:  FEBS Lett       Date:  1981-02-23       Impact factor: 4.124

4.  Primary structure of human insulin-like growth factor II.

Authors:  E Rinderknecht; R E Humbel
Journal:  FEBS Lett       Date:  1978-05-15       Impact factor: 4.124

5.  Evidence for the synthesis of a somatomedin similar to insulin-like growth factor I by chick embryo liver cells.

Authors:  G K Haselbacher; R Y Andres; R E Humbel
Journal:  Eur J Biochem       Date:  1980-10

6.  Purification and characterization of multiplication-stimulating activity. Insulin-like growth factors purified from rat-liver-cell-conditioned medium.

Authors:  A C Moses; S P Nissley; P A Short; M M Rechler; J M Podskalny
Journal:  Eur J Biochem       Date:  1980-01

7.  Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures. Homology with human insulin-like growth factor II.

Authors:  H Marquardt; G J Todaro; L E Henderson; S Oroszlan
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

8.  Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II.

Authors:  E Rinderknecht; R E Humbel
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

9.  Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum.

Authors:  A C Moses; S P Nissley; P A Short; M M Rechler; R M White; A B Knight; O Z Higa
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Insulin-like growth factor II (IGF II) in human brain: regional distribution of IGF II and of higher molecular mass forms.

Authors:  G K Haselbacher; M E Schwab; A Pasi; R E Humbel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

View more
  14 in total

1.  The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal.

Authors:  M Prisco; A Hongo; M G Rizzo; A Sacchi; R Baserga
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 2.  Somatomedins: chemical and functional characteristics of the different molecular forms.

Authors:  A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

3.  Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion.

Authors:  C M Buchanan; A R Phillips; G J Cooper
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

4.  Role of pro-IGF-II processing by proprotein convertase 4 in human placental development.

Authors:  Qing Qiu; Ajoy Basak; Majambu Mbikay; Benjamin K Tsang; Andrée Gruslin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-22       Impact factor: 11.205

5.  Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level.

Authors:  G K Haselbacher; J C Irminger; J Zapf; W H Ziegler; R E Humbel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.

Authors:  E T Shapiro; G I Bell; K S Polonsky; A H Rubenstein; M C Kew; H S Tager
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 7.  Insulin and insulin-like growth factor receptors in the nervous system.

Authors:  M Adamo; M K Raizada; D LeRoith
Journal:  Mol Neurobiol       Date:  1989 Spring-Summer       Impact factor: 5.590

8.  Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.

Authors:  W H Daughaday; B Trivedi; R C Baxter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

9.  Tissue-specific expression of insulin-like growth factor II mRNAs with distinct 5' untranslated regions.

Authors:  J C Irminger; K M Rosen; R E Humbel; L Villa-Komaroff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

10.  Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I.

Authors:  V R Sara; C Carlsson-Skwirut; C Andersson; E Hall; B Sjögren; A Holmgren; H Jörnvall
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.